RxDoctor Payments Data

Tobia Palma

Cardiovascular Disease · Palm Beach Gardens, FLNPI 1578507992

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $987 and has fallen 74.7% since, to $249 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.

$1,759in general payments, 2019–2025

Across 98 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$352
  • Amgen$295
  • Johnson & Johnson$196
  • Boehringer Ingelheim$131
  • Amarin Pharma, Inc.$111
  • E.r. Squibb & Sons, L.L.C.$105
  • plus $569 from 12 others

What the payments were for

  • Food & beverage$1,759100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,759 in reported general payments places this provider in the 40th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida →

Other cardiovascular disease in Palm Beach Gardens

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →